GENEVA, June 19 -- SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. filed a patent application (CN2025/134281) for “COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF COAGULATION FACTOR XI (FXI)”. With publication no. WO/2026/103722, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....